SCHEMBL6429861

SCHEMBL6429861

NC(=O)c1cccc(-c2ccccc2)c1-n1ccnn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 2/20 0.51
MAPK9 P45984 1/20 0.41
MAPK10 P53779 1/20 0.41
PARP1 P09874 6/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
IKBKB O14920 1/20 0.39
CHUK O15111 1/20 0.39
IKBKE Q14164 1/20 0.39
PKMYT1 Q99640 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HNF4A P41235 1/20 0.39
DHODH Q02127 1/20 0.39
CHRNB2 P17787 2/20 0.38
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38
CHRNA4 P43681 2/20 0.38
PARP2 Q9UGN5 1/20 0.37
PARP3 Q9Y6F1 1/20 0.37
KEAP1 Q14145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27830182 0.89 HNF4A (0.47) BCAT2NPC1RAB9AALDH1A1HNF4A
SCHEMBL2754380 0.83 GRM5 (0.45) BCAT2MAPK9MAPK10PARP1DHODH
SCHEMBL302445 0.80 MAPK9 (0.41) MAPK9MAPK10PARP1NPC1PARP2
SCHEMBL979249 0.80 MAPK9 (0.38) BCAT2MAPK9MAPK10IKBKBCHUK
SCHEMBL17910085 0.79 HCRTR1 (0.52) MAPK9MAPK10PARP1KEAP1
SCHEMBL6429867 0.78 MAPK9 (0.41) BCAT2MAPK9MAPK10PARP1NPC1
SCHEMBL15529579 0.77 MAPK9 (0.47) BCAT2MAPK9MAPK10NPC1RAB9A
SCHEMBL19554755 0.77 PARP1 (0.40) MAPK9MAPK10PARP1ALDH1A1KEAP1
SCHEMBL6430863 0.76 MAP3K5 (0.36) MAP3K5
SCHEMBL13739918 0.76 CYP3A4 (0.54) BCAT2PARP1NPC1RAB9AIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021031071-A1 AMIDE DERIVATIVE AND USE THEREOF IN MEDICINE 广东东阳光药业有限公司 2021-02-25 WO disclosed
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT BCAT2 1367/4885MAPK9 4057/4885MAPK10 4848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.